RxDoctor Payments Data

Margo Seymour

Psychiatric/Mental Health · Belle Glade, FLNPI 1194248443

Payments from drug & device makers

$1,658in general payments, 2019–2025

Across 71 payments — averaging $23.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$495
  • AbbVie$337
  • Teva Pharmaceuticals USA, Inc.$301
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$237
  • Otsuka America Pharmaceutical, Inc.$221
  • Lundbeck LLC$44
  • plus $22 from 1 others

What the payments were for

  • Food & beverage$1,54693%
  • Education$1127%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,658 in reported general payments places this provider in the 65th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida

Medicare billing

Part B allowed, 2024
$61,307
Medicare patients
71
Services billed
621

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Austedo XrDeutetrabenazine36$188,295
Abilify MaintenaAripiprazole18$49,586
VraylarCariprazine Hcl19$31,839
Risperidone ErRisperidone Microspheres16$29,929
Risperidone176$3,048
Fluphenazine Hcl16$2,011
Mirtazapine170$2,010
Quetiapine Fumarate202$1,915
Divalproex Sodium69$925
Duloxetine Hcl51$909
Valproic AcidValproic Acid (As Sodium Salt)23$684
Benztropine Mesylate70$670
Aripiprazole43$555
Lorazepam82$468
Hydroxyzine Hcl17$465

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo Xr$301$188,29536 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$221$49,58618 claims
AbbVieVraylar$337$31,83919 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,096 psychiatric/mental health providers in Florida.

Other psychiatric/mental health in Belle Glade

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →